- Capromorelin
-
- $16665.00 / 1kg
-
2025-08-22
- CAS:193273-66-4
- Min. Order: 1kg
- Purity: 99% min
- Supply Ability: 20 tons
- Capromorelin
-
- $10.00 / 1Kg/Bag
-
2022-02-25
- CAS:193273-66-4
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 10 Tons
- Capromorelin
-
- $10.00 / 1KG
-
2021-08-23
- CAS:193273-66-4
- Min. Order: 1KG
- Purity: >99%
- Supply Ability: 10T/month
|
| | Capromorelin Basic information |
| Product Name: | Capromorelin | | Synonyms: | Capromorelin;(3aR)-3a-benzyl-2-Methyl-5-(2-Methylalanyl-O-benzyl-D-seryl)-3-oxo-3,3a,4,5,6,7-hexahydro-2H-pyrazolo[4,3-c]pyridine;N-[(2R)-1-[(3aR)-2-Methyl-3-oxo-3a-(phenylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]-1-oxo-3-(phenylmethoxy)propan-2-yl]-2-amino-2-methylpropanamide;391;CP 424391; CP-424;391;CP-424;CP 424391;CP-424391, Capromorelin | | CAS: | 193273-66-4 | | MF: | C28H35N5O4 | | MW: | 505.61 | | EINECS: | | | Product Categories: | | | Mol File: | 193273-66-4.mol |  |
| | Capromorelin Chemical Properties |
| density | 1.25 | | pka | 15+-.0.46(Predicted) |
| | Capromorelin Usage And Synthesis |
| Uses | Treatment
and prevention of frailty; treatment of congestive
heart failure; treatment of catabolic illness (growth
hormone secretagogue). | | in vivo | Capromorelin increases plasma GH levels in an anesthesized rat model, with an ED50 value less than 0.05 mg/kg iv[1].
Capromorelin shows enhanced intestinal absorption in rodent models and exhibited superior pharmacokinetic properties, including high bioavailabilities in two animal species [F(rat)=65%, F(dog)=44%][1].
| | IC 50 | GHSR1a: 7 nM (Ki) |
| | Capromorelin Preparation Products And Raw materials |
|